Real-time enrollment status for this relapsed cll clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 10:20 PM UTC
| NCT Number | NCT06916767 |
| Recruiting Status | Recruiting |
| Condition | Relapsed CLL |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Paolo Caimi, MD |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of October 18, 2026: Clinical trial NCT06916767 is currently recruiting participants. This phase1 study for relapsed cll is actively seeking new participants at 1 location across the United States. The study is sponsored by Paolo Caimi, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06916767 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06916767 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.